Mechanisms Underlying Regulation of Susceptibility to CNS Autoimmunity by Commensal Lactobacillus Species
共生乳杆菌对中枢神经系统自身免疫易感性的调节机制
基本信息
- 批准号:10516032
- 负责人:
- 金额:$ 0.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2022-08-14
- 项目状态:已结题
- 来源:
- 关键词:Adoptive TransferAffectAllelesAnimal ModelAppointmentAstrocytesAutoimmunityAxonBlood - brain barrier anatomyBlood CirculationBrainCD8-Positive T-LymphocytesCNS autoimmune diseaseCNS autoimmunityCellsCentral Nervous System DiseasesChronicClinical TrialsCommunicationComplexCore FacilityCoupledDataDemyelinationsDevelopmentDietDiseaseDisease ResistanceDisease susceptibilityDistalEnvironmentEnvironmental Risk FactorEtiologyExhibitsExperimental Autoimmune EncephalomyelitisFlow CytometryFutureGenesGeneticGenomicsGranulocyte-Macrophage Colony-Stimulating FactorHealth SciencesHumanImmuneImmune systemImmunologyIncidenceIndolesInflammatoryIntakeInterventionKnowledgeLactobacillusLactobacillus reuteriLesionMass Spectrum AnalysisMedicineMentorsMentorshipMetabolicMicrobiologyMicrogliaMolecular GeneticsMultiple SclerosisMusMyelinNeuraxisNeurodegenerative DisordersNeurogliaNeurologicNeurologic DysfunctionsPathogenesisPathologyPeripheralPersonsPhasePhysiologyPopulationPredispositionProductionRegulationResource SharingRiskRisk FactorsRoleScienceSeverity of illnessShapesSiteSmokingStressSymptomsT cell responseT-LymphocyteTechniquesTestingTherapeuticTrainingTryptophanTryptophan Metabolism PathwayUniversitiesVermontVitamin Dblood-brain barrier permeabilizationcollegecommensal microbesdietarydisabilityeducational atmosphereeffector T cellgenome sequencinggut bacteriagut microbiomegut microbiotaimmunoregulationin vitro Assayin vivomembermetabolomicsmicrobialmicrobiomemicrobiotamicrobiota transplantationmicroorganismmouse modelmultidisciplinarymultiple sclerosis patientmultiple sclerosis treatmentneuroimmunologyneuroinflammationneuropathologynovelpersonalized medicineresident commensalsresponseskillswhole genomeyoung adult
项目摘要
Project Summary:
Multiple sclerosis (MS) is a chronic autoimmune central nervous system (CNS) disease and the leading cause
of non-traumatic neurological disability in young adults. The cause of MS is complex and cannot be ascribed to
any single gene with over 70% risk attributed to environmental factors. Recent studies identified an imbalance
in the human gut microbiome within MS patients as one such environmental risk, including depletion of the
Lactobacillus genus. Animal models support a causal role for the gut microbiome in MS, though the mechanism
remains unclear. Utilizing a mouse model of MS, we have identified disease resistant and susceptible
microbiomes, with stark differences in Lactobacillus species abundance and notable differences in their
circulating metabolic by-products known to modulate the immune system. Further, we have identified a single
commensal species, Lactobacillus reuteri (L. reuteri), which is sufficient to accentuate MS-like symptoms in the
mouse with whole genome sequencing indicating the necessary enzymatic machinery to account for the
observed differences in circulating metabolites. The focus of this proposal is to 1) determine the cellular
mechanisms underlying the effects of L. reuteri on EAE including both impact on infiltrating peripheral immune
cells and CNS resident glial cells and 2) determine the impact of L. reuteri-derived tryptophan metabolites on
neuroinflammation.
In direct support of the proposed studies, the training plan will develop the knowledge, expertise, scientific
communication skills and technical abilities in 1) mouse models of multiple sclerosis focused on host interactions
with the gut microbiome including directed microbiome manipulation, 2) immunology, with a focus on
neuroimmunology, flow cytometry, and functional assays in vitro and in vivo, 3) microbiology, with a focus on
commensal gut bacteria, their culture, isolation, genomic and metabolic characterization, and manipulation, 4)
neuropathology, with a focus on techniques to investigate CNS pathology to characterize inflammatory
demyelinating lesions in CNS autoimmune disease and blood brain barrier integrity analysis and 5)
metabolomics with a focus on bacterial metabolites and their effects on host physiology.
The training environment at the University of Vermont (UVM) is multidisciplinary with a collegial atmosphere that
stresses active mentorship and as such is uniquely appropriate to support this proposal which bridges
autoimmunity, CNS neuropathology and commensal microbiota. This is evidenced by co-mentors with
appointments in the departments of Biomedical and Health Sciences (BHSC), Microbiology and Molecular
Genetics (MMG), and Neurological Sciences which are connected to a hub of core facilities and the Larner
College of Medicine offering ample opportunity to share resources and promote in-person communication.
项目摘要:
多发性硬化症(MS)是一种慢性自身免疫性中枢神经系统(CNS)疾病,主要原因
年轻人非创伤性神经残疾的疾病。 MS的原因很复杂,不能归因于
任何归因于环境因素的风险超过70%的单一基因。最近的研究确定了失衡
在MS患者中的人类肠道微生物组中,作为一种这种环境风险,包括耗尽
乳杆菌属。动物模型支持MS中肠道微生物组的因果作用,尽管该机制
仍然不清楚。利用MS的小鼠模型,我们已经确定了抗病性和易感性
微生物组,乳酸杆菌的丰度有明显的差异,其显着差异
已知可调节免疫系统的循环代谢副产品。此外,我们已经确定了一个
共生物种,Reuteri乳酸菌(L. Reuteri),足以强调MS样症状
带有整个基因组测序的鼠标,表明必要的酶促机器来解释
观察到循环代谢产物的差异。该建议的重点是1)确定细胞
L. Reuteri对EAE影响的基础机制,包括对浸润外周免疫的影响
细胞和中枢神经系统固定的神经胶质细胞和2)确定Reuteri衍生的色氨酸代谢产物对
神经炎症。
为了直接支持拟议的研究,培训计划将发展知识,专业知识,科学
1)多发性硬化症的鼠标模型的沟通技巧和技术能力,专注于宿主互动
肠道微生物组(包括定向微生物组操纵),2)免疫学,重点
神经免疫学,流式细胞术和体外和体内功能测定,3)微生物学,重点是
共生肠道细菌,它们的培养,分离,基因组和代谢表征以及操纵,4)
神经病理学,重点是研究CNS病理学以表征炎症的技术
中枢神经系统自身免疫性疾病和血脑屏障完整性分析的脱髓鞘病变和5)
代谢组学的重点是细菌代谢物及其对宿主生理的影响。
佛蒙特大学(UVM)的培训环境是多学科的,有着大学氛围,
压力积极的指导,因此是独特的,适合支持该提议的桥梁
自身免疫性,CNS神经病理学和共生微生物群。该联合会与
生物医学和健康科学系(BHSC),微生物学和分子的任命
遗传学(MMG)和与核心设施和Larner相连的神经科学
医学院提供了足够的机会共享资源并促进面对面的交流。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Theresa Lynn Montgomery其他文献
Theresa Lynn Montgomery的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Theresa Lynn Montgomery', 18)}}的其他基金
Mechanisms Underlying Regulation of Susceptibility to CNS Autoimmunity by Commensal Lactobacillus Species
共生乳杆菌对中枢神经系统自身免疫易感性的调节机制
- 批准号:
10312423 - 财政年份:2021
- 资助金额:
$ 0.01万 - 项目类别:
相似国自然基金
KIR3DL1等位基因启动子序列变异影响其差异表达的分子机制研究
- 批准号:82200258
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
KIR3DL1等位基因启动子序列变异影响其差异表达的分子机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NUP205双等位基因突变影响纤毛发生而致内脏转位合并先天性心脏病的机理研究
- 批准号:82171845
- 批准年份:2021
- 资助金额:54.00 万元
- 项目类别:面上项目
NUP205双等位基因突变影响纤毛发生而致内脏转位合并先天性心脏病的机理研究
- 批准号:
- 批准年份:2021
- 资助金额:54 万元
- 项目类别:面上项目
全基因组范围内揭示杂交肉兔等位基因特异性表达模式对杂种优势遗传基础的影响
- 批准号:32102530
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 0.01万 - 项目类别:
Alpha-Synuclein-Specific T cells in Parkinson's Disease Pathogenesis
帕金森病发病机制中的α-突触核蛋白特异性 T 细胞
- 批准号:
10752172 - 财政年份:2023
- 资助金额:
$ 0.01万 - 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 0.01万 - 项目类别:
Gamma delta T cell based melanoma therapies
基于 Gamma Delta T 细胞的黑色素瘤疗法
- 批准号:
10365762 - 财政年份:2021
- 资助金额:
$ 0.01万 - 项目类别:
Mechanisms Underlying Regulation of Susceptibility to CNS Autoimmunity by Commensal Lactobacillus Species
共生乳杆菌对中枢神经系统自身免疫易感性的调节机制
- 批准号:
10312423 - 财政年份:2021
- 资助金额:
$ 0.01万 - 项目类别: